Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 12 Seiten
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers(16), H. 3 - ISSN 2072-6694
In: © 2024 by the authors., Basel
- Event
-
Veröffentlichung
- (where)
-
Jena
- (who)
-
Friedrich-Schiller-Universität Jena
- (when)
-
2024
- Creator
-
Schulz, Felicitas
Jäger, Paul Sebastian
Tischer, Johanna
Fraccaroli, Alessia
Bug, Gesine
Hausmann, Andreas
Baermann, Ben-Niklas
Tressin, Patrick
Hoelscher, Alexander
Kasprzak, Annika
Nachtkamp, Kathrin
Schetelig, Johannes
Hilgendorf, Inken
Germing, Ulrich
Dietrich, Sascha
Kobbe, Guido
- Contributor
-
Ying, Mingyao
- URN
-
urn:nbn:de:gbv:27-dbt-60376-3
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schulz, Felicitas
- Jäger, Paul Sebastian
- Tischer, Johanna
- Fraccaroli, Alessia
- Bug, Gesine
- Hausmann, Andreas
- Baermann, Ben-Niklas
- Tressin, Patrick
- Hoelscher, Alexander
- Kasprzak, Annika
- Nachtkamp, Kathrin
- Schetelig, Johannes
- Hilgendorf, Inken
- Germing, Ulrich
- Dietrich, Sascha
- Kobbe, Guido
- Ying, Mingyao
- Friedrich-Schiller-Universität Jena
Time of origin
- 2024
Other Objects (12)
Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis
Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination
Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
Real-world experience with venetoclax-based therapy for patients with myeloid sarcoma
Cardiotoxicity of venetoclax in patients with acute myeloid leukemia: comparison with anthracyclines
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
Venetoclax: A Novel Therapeutic Agent for CLL with CNS Involvement
RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
Synchronous Malignancies: Pathological Analysis of Three Patients, Each with Dual Malignancies
Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia
Value transfer in discriminative conditioning with pigeons
Unveiling novel hypoxia-specific dependencies and venetoclax-based targets in hematologic malignancies : proteomic and CRISPR/Cas9 screening approaches
Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis
Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination
Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
Real-world experience with venetoclax-based therapy for patients with myeloid sarcoma
Cardiotoxicity of venetoclax in patients with acute myeloid leukemia: comparison with anthracyclines
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
Venetoclax: A Novel Therapeutic Agent for CLL with CNS Involvement
RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
Synchronous Malignancies: Pathological Analysis of Three Patients, Each with Dual Malignancies
Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia
Value transfer in discriminative conditioning with pigeons
Unveiling novel hypoxia-specific dependencies and venetoclax-based targets in hematologic malignancies : proteomic and CRISPR/Cas9 screening approaches
Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis
Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination
Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
Real-world experience with venetoclax-based therapy for patients with myeloid sarcoma
Cardiotoxicity of venetoclax in patients with acute myeloid leukemia: comparison with anthracyclines
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
Venetoclax: A Novel Therapeutic Agent for CLL with CNS Involvement
RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
Synchronous Malignancies: Pathological Analysis of Three Patients, Each with Dual Malignancies
Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia
Value transfer in discriminative conditioning with pigeons